BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, May 7, 2026
Home » Authors » Amanda Pedersen

Amanda Pedersen

Articles

ARTICLES

FDA clears Solitaire FR for ischemic stroke victims

March 6, 2012
By Amanda Pedersen
Covidien (Mansfield, Massachusetts) reported that the Solitaire FR revascularization device has been cleared by FDA. The device is intended to restore blood flow to the brain in patients suffering acute ischemic stroke by mechanically removing blood clots from blocked vessels.
Read More

GE enhances web-based program for FHR monitoring education

March 5, 2012
By Amanda Pedersen

Jarvik Heart gets conditional approval for Jarvik 2000 trial

Feb. 29, 2012
By Amanda Pedersen
Medical innovation is often more of a marathon than a sprint. That seems to be the case for Jarvik Heart (New York), a private company founded in 1988 by Robert Jarvik, MD, to conduct R&D on advanced concepts for miniature artificial hearts. The company recently reached an important checkpoint that brings it closer to the finish line - the line that would allow its artificial heart to be used as a permanent support for end-stage congestive heart failure patients who are not candidates for transplant.
Read More

NewCo on the Block: Vessix to compete with big fish in renal denervation sea

Feb. 27, 2012
By Amanda Pedersen
To say that the potential size of the renal denervation pond is huge might be an understatement. With as much as a third of the world's population suffering from hypertension and a third or more of that population falling into the drug-resistant category it's no wonder physicians are excited about a new percutaneous catheter-based procedure aimed at helping those with resistant hypertension.
Read More

Agreements/contracts: GE and Masimo expand OEM partnership for rainbow SET

Feb. 24, 2012
By Amanda Pedersen

NinePoint to evaluate Nvision VLE for Barrett's esophagus

Feb. 23, 2012
By Amanda Pedersen

Enzo to offer ColonSentry for cancer risk assessment

Feb. 22, 2012
By Amanda Pedersen

HHS says 86 million benefited from preventive care in '11

Feb. 16, 2012
By Amanda Pedersen

A picture is worth 1,000 what?

Feb. 15, 2012
By Amanda Pedersen
We already know that a picture is worth a thousand words, but did you know it might also be worth a thousand calories? A new smartphone application is being developed at Purdue University (West Lafayette, Indiana) to help the health and diet conscious track their caloric intake by taking a picture of their food. This caught my attention for two reasons: One, I’m sort of turning into a health-app junkie. I am currently tracking every bite of food, every visit to the bathroom, every headache, my sleep patterns, and my menstrual cycle. Oh yeah, and I check on my heart...
Read More

2012 continues to look sluggish, but expected to pick up in 2013

Feb. 15, 2012
By Amanda Pedersen
View All Articles by Amanda Pedersen

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 6, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Strategy compass

    Bio Korea 2026: US policy risks shift to execution framework

    BioWorld
    Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
  • The epidermal growth factor receptor in the inactive (left) and active (right) form.

    Cytospire raises £61M series A to target EGFR in solid tumors

    BioWorld
    Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
  • Regulatory actions for May 5, 2026

    BioWorld
    Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing